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Abstract
Background: Different histo-pathological types and treatment response patterns of  Idiopathic nephrotic syndrome (INS) have 
been associated with differences in ethnicity and geographical location.  
Objective: To provide an update on the steroid response and renal histo-pathological pattern in children treated for INS.
Method: Medical records of  children with INS treated at the Charlotte Maxeke Johannesburg Academic Hospital were reviewed.
Results: Mean age was 5.3 years ± 2.8. The majority (68.1%) of  the 163 children were of  the black racial group. The highest 
rate of  INS was seen in the 2-6 year age group (71.2%). The black racial group had the highest rate (42/111; 37.8%) of  focal 
segmental glomerulosclerosis (FSGS), and the white race had the highest rate (9/14; 64.3%) of  minimal change disease (MCD). 
Ninety four (57.7%) patients were steroid sensitive (SSNS) while 69 patients (42.3%) were steroid resistant (SRNS). Minimal 
change disease was the most common histo-pathological type seen in SSNS (60%), while FSGS was the most common observed 
in patients who had SRNS (65.2%).
Conclusion: There appears to be a higher rate of  FSGS in all the racial groups, and also a higher rate of  MCD in the black race 
group, when compared to previous reports.
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The spectrum of  idiopathic nephrotic syndrome (INS) in 
African countries seems to be different from other parts 
of  the world suggesting that an interaction of  genetic 
and environmental factors plays an important role in the 
pathogenesis of  INS1,2. Worldwide, a significant number 
of  cases of  INS are usually steroid sensitive, while some 
cases will be diagnosed as having steroid unresponsive 
disease3-5.
The histo-pathological pattern of  presentation, its chang-
ing pattern and advances in the treatment of  childhood 
INS have been reported widely6-12. Childhood INS is most 
commonly caused by one of  several idiopathic diseases: 
Minimal-change disease (MCD), focal segmental glomer-
ulosclerosis (FSGS) and, less commonly, idiopathic me-
sangial proliferative glomerulonephritis (MesPGN)3,4,13. 
These various histo-pathological features have been 
strongly associated with differences in response to cor-
ticosteroid therapy, subsequent clinical course and prog-
nosis4,13. The general impression is that the histo-patho-
logical pattern of  INS has been changing despite a stable 
incidence of  the disease in the last 30 years. This is as 
noted by the increasing reported incidence of  FSGS6,14-16.
Idiopathic nephrotic syndrome remains an important 
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cause of  childhood glomerulopathy. A better under-
standing of  the presentation, the steroid response pattern 
and the histo-pathological pattern of  childhood INS is 
important in determining future guidelines for effective 
management of  the disease.  
In this study, we aimed to describe the steroid response 
and renal histo-pathological pattern in a cohort of  chil-
dren treated for INS in the Division of  Paediatric Ne-
phrology, Charlotte Maxeke Johannesburg Academic 
Hospital, Johannesburg, South Africa.
 
Methods
This retrospective study reviewed children (2-16 years) 
with INS treated by the Division of  Paediatric Nephrolo-
gy at Charlotte Maxeke Johannesburg Academic Hospital 
between January 2004 and December 2013. Only children 
who had at least 6 months of  follow up after onset of  
the disease were included in the study. Children with evi-
dence of  chronic renal impairment prior to the diagnosis 
of  INS (estimated glomerular filtration rate (eGFR) ≤60 
mL/min/1.73 m2) were excluded from the study. Demo-
graphic and clinical information were obtained from the 
patients’ records.
Additional information on renal biopsies were obtained 
from the records. The renal biopsies were carried out 
under ultrasound guidance and the indications for renal 
biopsy were steroid resistance, frequent relapse, steroid 
dependence and an atypical presentation such as the pres-
ence of  hypertension, haematuria on presentation, or age 
greater than, or equal to, 10 years. The renal tissues were 
subject to light microscopy, immunofluorescence and 
electron microscopy.
Data analysis
All data were collated, checked and analysed using a com-
puter based statistical package STATA version 13.1. Con-
tinuous parameters were reported as mean and standard 
deviation while categorical variables were presented as 
percentages and bar charts. Associations between groups 
were determined using chi-square testing and bilateral 
Fisher’s exact tests. A p value < 0.05 was regarded as sta-
tistically significant.
Ethics and permission
The study was approved by the University of  the Witwa-
tersrand, Human Research Ethics Committee (Protocol 
M150234) and was conducted in conformance with the 
Helsinki Declaration, Good Clinical Practice and within 
the laws and regulations of  South Africa.
Definition of  terms
1. Steroid response pattern17:
a. Steroid sensitive nephrotic syndrome (SSNS) (initial respond-
er): Attainment of  remission within initial 4 weeks of  
corticosteroid therapy.
b. Steroid dependent nephrotic syndrome (SDNS): Two consec-
utive relapses during corticosteroid therapy, or within 14 
days of  ceasing therapy.
c. Steroid resistant nephrotic syndrome (SRNS) (initial non-re-
sponder/steroid resistance): Failure to achieve complete 
remission after 8 weeks of  corticosteroid therapy.
2. Remission17: Urine protein/creatinine ratio (uPCR) < 
200 mg/g (< 0.02 g/mmol) or <1+ of  protein on urine 
dipstick for 3 consecutive days.
3. Relapse17: Urine PCR ≥ 2000 mg/g (≥ 0.2 g/mmol) 
or ≥ 3+ protein on urine dipstick for 3 consecutive days:
a. Infrequently relapsing nephrotic syndrome (IFRNS): One re-
lapse within 6 months of  initial response, or one to three 
relapses in any 12 month period.
b. Frequently relapsing nephrotic syndrome (FRNS): Two or 
more relapses within 6 months of  initial response, or four 
or more relapses in any 12 month period.
Results
A total of  163 children who met the study criteria were 
recruited. There were 97 (59.5%) males and 66 (40.5%) 
females with a male to female ratio of  1.5:1. The mean 
age of  the children at the time of  presentation was 5.3 
years ± 2.8. The mean follow-up period was 60 months 
± 36.9.
At presentation, the majority of  the patients were in the 
2-6 year age group (71.2%) (Table 1). The majority of  the 
patients in the cohort were of  the black race (68.1%) and 
the black race made up the highest number in all the age 
groups (Table 1). Common features at presentation in-
clude hypercholesterolaemia (122; 74.8%), hypertension 
(77; 47.2%), haematuria (32; 19.6%) and infections (respi-
ratory tract infection 35, peritonitis 21 and UTI 3).






Table 1: The age group distribution according to the racial groups 
 
Racial group (%) 
Age group 
(year) Black Asian Mixed Race White Total 
            
2 – 6 71 (61.2) 20 (17.2) 14 (12.1) 11 (9.5) 116 (100) 
            
7 – 10 30 (83.3) 1 (2.8) 2 (5.6) 3 (8.3) 36 (100) 
            
11 – 16 10 (90.9) 1 (9.1) 0 (0.0) 0 (0.0) 11 (100) 
            
One hundred and thirty-two (80.9%) of  the patients un-
derwent a renal biopsy. The indications for renal biopsy 
can be seen in Figure 1. The most common histopatho-
logical lesion observed was MCD (52.3%) (Table 2). The 
mean age at presentation of  MCD and FSGS was similar, 
64.5 months ± 28.3 and 67.0 months ± 39.8 respectively. 
The mean age at presentation for MesPGN was higher 
(94.0 months ± 28.6) when compared to the others. The 
black race had a similar rate of  MCD (38.8%) and FSGS 
(37.8%) while the white race had a higher rate of  MCD 





Table 2: The different histopathological lesions 
 
  No Biopsy MCD FSGS MesPGN Total 
Age group (year)           
2 – 6 26 (22.4) 50 (43.1) 37 (31.9) 3 ( 2.6) 116 (100) 
7 – 10 4 (11.1) 17 (47.2) 13 (36.1) 2 (5.6) 36 (100) 
11 – 16 1 (9.1) 2 (18.2) 7 (63.6) 1 (9.1) 11 (100) 
          p=0.116 
            
Racial group           
Black 21 (18.9) 43 (38.8) 42 (37.8) 5 (4.5) 111 (100) 
Asian 6 (27.3) 9 (40.9) 7 (31.8) 0 (0.0) 22 (100) 
Mixed 2 (12.5) 8 (50.0) 6 (37.5) 0 (0.0) 16 (100) 
White 2 (14.3) 9 (64.3) 2 (14.3) 1 (7.1) 14 (100) 
          p=0.604 
            
Clinical type           
SSNS 20 (30.8) 39 (60) 6 (9.2) 0 (0.0) 65 (100) 
SDNS 5 (17.2) 18 (62.1) 6 (20.7) 0 (0.0) 29 (100) 
SRNS 6 (8.7) 12 (17.4) 45 (65.2) 6 (8.7) 69 (100) 
          p<0.001 
All of  the patients received prednisolone 2 mg/kg as a 
daily dose for at least 4 weeks. The steroid response pat-
tern was as follows; 94/163 (57.7%) patients had SSNS, 
and SRNS was present in 69/163 patients (42.3%). Of  
the patients who were initially steroid sensitive, 55/94 
(58.5%) turned out to be infrequent relapsers, 10/94 
(10.6%) became frequent relapsers and 29/94 (30.9%) 
became steroid dependent.
Minimal change disease was the most common histo-
pathological lesion (60%) seen in SSNS, while FSGS was 
the most common lesion (65.2%) observed in patients 
who had SRNS. Steroid sensitive NS was seen more in 
the Asian (59.1%) and white groups (50%) while the 
mixed race and black racial groups had a higher incidence 
of  SRNS (50% and 46% respectively) (Table 3).
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Table 3: The relationship between the racial groups and the steroid response 
patterns 
  Steroid response pattern (%) 
Racial group SSNS SDNS SRNS Total 
Black 39 (35.1) 21 (18.9) 51 (46.0) 111 (100) 
          
Asian 13 (59.1) 3 (13.6) 6 (27.3) 22 (100) 
          
Mixed 6 (37.5) 2 (12.5) 8 (50.0) 16 (100) 
          
White 7 (50.0) 3 (21.4) 4 (28.6) 14 (100) 
          
Total 65 (39.9) 29 (17.8) 69 (42.3) 163 (100) 
        p=0.434 
 
Steroid sparing drugs (SSDs) such as alkylating agent 
(Cyclophosphamide), calcineurin inhibitors (Cyclosporin, 
Tacrolimus) and antiproliferative agents (Mycophenolate 
Mofetil) were used in patients who were steroid depen-
dent and steroid resistant. Nine of  the SRNS patients 
were able to achieve remission with the use of  SSDs. Sev-
en of  these remained in remission afterwards on SSDs 
and corticosteroid treatment, while two developed a fre-
quently relapsing picture while on SSDs and corticoste-
roid treatment (Table 4).
The highest rate of  resistance to all treatment after a 
mean follow up of  60 months was seen among children 
of  the mixed race and black racial groups (50.0% and 
40.5% respectively) (Table 4).
 
Table 4: The outcome of INS at a mean follow up period of 60 months 
 












FRNS Resistant to all treatment Total 
Steroid 
response 
            
SSNS 53 (81.5) 1 (1.5) 0 (0.0) 10 (15.5) 1 (1.5) 65 (100.0) 
SDNS 0 (0.0) 27 (93.1) 2 (6.9) 0 (0.0) 0 (0.0) 29 (100.0) 
SRNS 0 (0.0) 0 (0.0) 7 (10.1) 2 (2.9) 60 (87.0) 69 (100.0) 
            p<0.001 
              
Racial group             
Black 34 (30.7) 22 (19.8) 5 (4.5) 5 (4.5) 45 (40.5) 111 (100.0) 
Asian 11 (50.0) 2 (9.1) 1 (4.6) 3 (13.6) 5 (22.7) 22 (100.0) 
Mixed 3 (18.7) 1 (6.3) 2 (12.5) 2 (12.5) 8 (50.0) 16 (100.0) 
White 5 (35.7) 3 (21.4) 1 (7.2) 2 (14.3) 3 (21.4) 14 (100.0) 
            p=0.135 
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Discussion
This study found a mean age at presentation that is simi-
lar to previous studies1,6,7,9,12,18,19, but lower than that previ-
ously reported by Bhimma et al in Durban, South Africa1. 
Although we expected our study cohort to have a simi-
lar age of  presentation to that of  the Durban study, the 
Durban study had a higher percentage of  Asian patients 
in their cohort than we had in ours, and this may explain 
why their mean age of  presentation was closer to that 
observed in studies from India and Pakistan than to that 
of  our study18,20.
In our study, black children made up the predominant 
race group (68.1%) and this is similar to a previous study 
from Pretoria, South Africa that reported a cohort made 
up predominantly of  black patients (77.7%)6. The study 
from Pretoria had only two racial groups in the study, 
white and black, and this may explain the greater per-
centage of  black patients reported in their findings as 
compared to our study. On the contrary, the study from 
Durban reported the Indian (Asian) race to be the pre-
dominant group (52.5%), with the black race representing 
only 43.3% of  the patients1.
A high rate of  hypertension (47.2%) was recorded as one 
of  the common presenting features of  our patients. This 
is not in keeping with the majority of  studies which have 
specifically looked at children with INS (15-31%)9,10,20-23, 
and may be related to the higher rate of  FSGS (43.2%) 
documented in our study. Furthermore, a large number 
of  our patients (68.1%) were of  the black racial group 
when compared to the other studies, and the risk of  hy-
pertension has been associated with the black race in the 
past24-26.
Minimal change disease (MCD) accounted for the most 
common histo-pathologic variant observed in our cohort 
(52.3%). This is similar to the report from Pakistan where 
MCD accounted for 51.2%20. Other studies, including 
previous South African studies, have reported a much 
lower rate of  MCD (<36%)1,6,12,18,19.  It is possible that 
these apparent differences in the rate of  MCD in children 
may be due to variations in the indications for biopsy in 
the different studies (where the most common indication 
was steroid resistance), rather than actual differences in 
the rate of  MCD in the various population groups stud-
ied.
Focal segmental glomerulosclerosis (FSGS) was found to 
have a rate of  43.2% in our study which is higher than the 
rates reported in previous South African studies namely 
28.5% in the Durban study, 25% in the Pretoria study and 
31.3% in a study from Johannesburg1,6,27. One possible 
reason for this finding may be the decline of  infection 
related nephrotic syndrome (NS). Up until now this was 
one of  the most common causes of  NS in children and 
presented as other histo-pathological sub-types such as 
Membranous Nephropathy (MN) and Membranoprolif-
erative glomerulonephritis (MPGN)1. Other possible rea-
sons include the theory that suggests the transition of  
MCD to FSGS in selected cases, although this is yet to 
be proven, and the very real possibility of  misdiagnosing 
FSGS as MCD due to technical challenges or sampling 
error28,29. As has been also noted in previous studies, in 
our cohort, the age of  presentation of  FSGS was most 
common in the age group of  2-6 years1,12.
Mesangial proliferative glomerulonephritis (MesPGN) 
was the least common histo-pathologic variant observed 
in our study (4.5%). Even though higher rates have been 
reported from India (11.4%), Turkey (17%) and the US 
(25%), our findings are in keeping with rates reported in 
previous South African studies1,6,10,12,18.
Ethnicity has been implicated in playing a role in the his-
topathological types of  INS. Studies with diverse patient 
cohorts have reported higher rates of  FSGS in the black 
race group1,6,10. Similarly, in our group FSGS made up a 
larger proportion of  cases in the black race group when 
compared to the other race groups.
Despite the inhomogeneous nature of  our cohort, we ob-
served an initial response rate to steroid therapy of  57.7% 
and a steroid resistance rate of  42.3%. This is almost sim-
ilar to the steroid response pattern reported from Paki-
stan, even though they had a much more homogeneous 
cohort20. Studies from New Zealand and Iran reported 
much higher steroid response rates of  80.4% and 75.2% 
respectively22,23. A similar rate of  frequent relapse (10.6%) 
and steroid dependence (17.8%) was observed in our ste-
roid sensitive group of  patients to that which was report-
ed in the study from New Zealand23.
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Although we observed a high rate of  steroid resistance 
among the black racial group in our study, this group 
also had a high rate of  steroid sensitivity (35.1%). This is 
contrary to reports from previous South African studies 
and the traditional belief  that most black children are ste-
roid resistant1,6,27. We also observed that the mixed racial 
group exhibited a similar steroid response pattern to the 
black racial group.
A small fraction of  the MCD group was steroid resistant 
(17.4%), and likewise a small fraction of  the FSGS group 
was steroid sensitive (21%). These findings are in keeping 
with findings reported elsewhere12,18,20,22,23.
Strength and limitations
This study provides an update on children with INS and 
also highlights the higher rate of  FSGS in all racial groups 
when compared to previous studies.  The main limita-
tions of  our study are that it is retrospective and that we 
could not compare the response rate to other agents used 
in SRNS.
Conclusion
We found higher rates of  MCD, and also of  favourable 
steroid response patterns, in our black race group than 
have been previously reported from South Africa. Of  
concern is our finding of  a higher rate of  FSGS in all the 
racial groups when compared to previous studies and we 
are not sure if  this represents a new trend that FSGS is 
increasing in our population. If  our finding of  a higher 
rate of  FSGS when compared to previous South African 
studies is real, this may mean that in the future we might 
begin to see an increase in the rate of  steroid resistance 
among South African children with INS.
We suggest a prospective, multicentre study on childhood 
INS in Africa for better understanding of  the disease in 
order to tailor treatment regimens unique to our patients.
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